Immune-inflammatory, metabolic and hormonal biomarkers are associated with the clinical forms and disability progression in patients with multiple sclerosis: A follow-up study
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 410, 116630
Abstract
No abstract availableKeywords
Funding Information
- Novartis Biosciences S.A (CFTY720DBR07T)
This publication has 73 references indexed in Scilit:
- Homocysteine, vitamin B12 and folate levels in Iranian patients with Multiple Sclerosis: A case control studyClinical Neurology and Neurosurgery, 2013
- The genetics of multiple sclerosis: an up‐to‐date reviewImmunological Reviews, 2012
- Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975–2009)Multiple Sclerosis Journal, 2011
- IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating diseaseTrends in Immunology, 2011
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosisAnnals of Neurology, 2010
- Body size and risk of MS in two cohorts of US womenNeurology, 2009
- Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosisNeurology, 2009
- Hyperhomocysteinemia, Oxidative Stress, and Cerebral Vascular DysfunctionStroke, 2004
- Rating neurologic impairment in multiple sclerosisNeurology, 1983